Skip to main content
Clinical Trials/NCT06416501
NCT06416501Not yet recruitingNot Applicable

The Impact of Colorectal Cancer Screening on Surgical Outcomes

Fudan University1 site in 1 country4,000 target enrollmentStarted: May 11, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
4,000
Locations
1
Primary Endpoint
overall survival

Study Overview

Brief Summary

This study aims to investigate the pathological characteristics and surgical outcomes of stage III CRC patients detected through screening.

Data extracted from the database included the following patient information: age at diagnosis, gender, tumor location, neoadjuvant therapy, surgical procedures, histologic type, differentiation, vascular invasion, perineural invasion, pathological T stage, pathological N stage, and survival outcomes.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who underwent radical surgery for CRC, had confirmed stage III CRC through postoperative pathology, had no prior history of cancer before surgery, and had clear cancer detection information.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

overall survival

Time Frame: the duration from the initial treatment to either death from any cause or the last recorded follow-up, whichever came first. Assessed up to 100 months.

The duration from the initial treatment to either death from any cause or the last recorded follow-up, whichever came first. Assessed up to 100 months.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

LI XIN-XIANG

professor

Fudan University

Study Sites (1)

Loading locations...

Similar Trials